Key result
Echinochrome A prevents post-MI left ventricular systolic dysfunction and adverse remodeling in mice.
Why the study?
Echinochrome A inhibits acute myocardial ferroptosis after ischemia/reperfusion, but its chronic effect on heart failure was unknown.
Does continuous administration of Echinochrome A prevent chronic heart failure and structural remodeling after myocardial infarction in mice?
Does continuous administration of Echinochrome A prevent chronic heart failure and structural remodeling after myocardial infarction in mice?
Echinochrome A prevents post-myocardial infarction chronic heart failure and remodeling in mice, highlighting a novel therapeutic mechanism involving the preservation of intracellular reactive sulfur species catabolism.
Hypothesis-generating for Echinochrome A in post-MI remodeling; leaves open translation to human heart failure therapy.
Abnormal sulfide catabolism, especially the accumulation of hydrogen sulfide (H2S) during hypoxic or inflammatory stresses, is a major cause of redox imbalance-associated cardiac dysfunction. Polyhydroxynaphtoquinone echinochrome A (Ech-A), a natural pigment of marine origin found in the shells and needles of many species of sea urchins, is a potent antioxidant and inhibits acute myocardial ferroptosis after ischemia/reperfusion, but the chronic effect of Ech-A on heart failure is unknown. Reactive sulfur species (RSS), which include catenated sulfur atoms, have been revealed as true biomolecules with high redox reactivity required for intracellular energy metabolism and signal transduction. Here, we report that continuous intraperitoneal administration of Ech-A (2.0 mg/kg/day) prevents RSS catabolism-associated chronic heart failure after myocardial infarction (MI) in mice. Ech-A prevented left ventricular (LV) systolic dysfunction and structural remodeling after MI. Fluorescence imaging revealed that intracellular RSS level was reduced after MI, while H2S/HS− level was increased in LV myocardium, which was attenuated by Ech-A. This result indicates that Ech-A suppresses RSS catabolism to H2S/HS− in LV myocardium after MI. In addition, Ech-A reduced oxidative stress formation by MI. Ech-A suppressed RSS catabolism caused by hypoxia in neonatal rat cardiomyocytes and human iPS cell-derived cardiomyocytes. Ech-A also suppressed RSS catabolism caused by lipopolysaccharide stimulation in macrophages. Thus, Ech-A has the potential to improve chronic heart failure after MI, in part by preventing sulfide catabolism.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) studied myocardial infarction. Echinochrome A vs. vehicle (0.9% sodium chloride) was evaluated on left ventricular systolic dysfunction and structural remodeling. Continuous intraperitoneal administration of Echinochrome A at 2.0 mg/kg/day prevented left ventricular systolic dysfunction and structural remodeling after myocardial infarction in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: